+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
5-in-1 DTaP-Hib-IPV Vaccine Market - Global Forecast to 2030- Product Image
5-in-1 DTaP-Hib-IPV Vaccine Market - Global Forecast to 2030- Product Image
Sale

5-in-1 DTaP-Hib-IPV Vaccine Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138475
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The five-in-one DTaP-Hib-IPV vaccine market is experiencing significant momentum, propelled by innovations in combination immunization and escalating demand for streamlined vaccine delivery solutions. Senior decision-makers are focusing on operational efficiency, supply resilience, and evolving compliance standards to drive growth and maintain a competitive edge.

Market Snapshot: Five-in-one DTaP-Hib-IPV Vaccine Market

The global five-in-one DTaP-Hib-IPV vaccine market is reshaping pediatric immunization, consolidating protection against diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and poliovirus in a single formulation. This market benefits from increasing healthcare digitalization, persistent public health priorities, and policy-driven adoption strategies. Recent regulatory reforms expedite approval pathways and reinforce post-marketing surveillance, enabling rapid expansion while upholding product safety and efficacy. Heightened awareness and partnerships between public health agencies and private stakeholders continue to support national and local immunization infrastructure growth.

Scope & Market Segmentation

  • End Users: General clinics, pediatric clinics, government hospitals, private hospitals, immunization centers
  • Distribution Channels: Government medical stores, private hospital pharmacies, public hospital pharmacies, online pharmacies, chain pharmacies, independent retail pharmacies
  • Administration Routes: Intramuscular injection, subcutaneous injection
  • Dosage Forms: Freeze-dried, liquid
  • Packaging Formats: Five-dose vials, ten-dose vials, single-dose prefilled glass syringes, single-dose prefilled plastic syringes
  • Age Groups: Children, infants, toddlers
  • Regions: Americas (including United States, Canada, Brazil, Argentina, Mexico), Europe Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, and additional markets)
  • Leading Companies: Sanofi Pasteur S.A., GlaxoSmithKline plc, Serum Institute of India Private Limited, PT Bio Farma (Persero) Tbk, Walvax Biotech Co., Ltd, Sinovac Biotech Ltd, Bharat Biotech International Limited, Biological E. Limited, Chengdu Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co., Ltd

Key Takeaways for Senior Decision-Makers

  • Combination vaccines streamline immunization processes, enhancing appointment compliance and minimizing missed or delayed doses across pediatric populations.
  • Integration with digital health solutions—such as electronic immunization registries and patient engagement platforms—enables precise coverage monitoring and supports data-driven outreach strategies.
  • Supply chain agility is achieved through adoption of modular manufacturing, diversified sourcing, and traceability measures, addressing both demand fluctuations and risk of disruption.
  • Strategic partnerships foster technology transfer and innovation in thermostable formulations and microarray platforms, increasing distribution flexibility and shelf-life stability.
  • Regional disparities require tailored expansion strategies that account for varying infrastructure maturity, regulatory harmonization, and funding capabilities in key markets across the Americas, EMEA, and Asia-Pacific.

Tariff Impact: Navigating Policy-Driven Cost Pressures

The implementation of targeted United States tariffs in 2025 introduced new cost variables throughout the vaccine manufacturing and distribution ecosystem. Affected components require re-evaluation of procurement, alternative sourcing, and revised transportation routes. Manufacturers, governments, and payers are exploring exemptions, volume-based pricing, and domestic production expansion to sustain cost-efficiency and continuity. Transparent collaboration is crucial in balancing tariff-induced price shifts with ongoing public health commitments.

Five-in-one DTaP-Hib-IPV Vaccine: Methodology & Data Sources

This report employs a blended methodology, leveraging authoritative secondary sources—including regulatory filings, peer-reviewed literature, and industry reports—alongside direct interviews with executives, program directors, and supply chain specialists. Analytical rigor is ensured by validation workshops, source triangulation, and robust data consistency checks for actionable insights.

Why This Report Matters

  • Guides planning and risk management decisions through granular segmentation and analysis of distribution, technology, and regional factors.
  • Delivers strategic recommendations on digital health integration and supply chain resilience to strengthen immunization program effectiveness.
  • Supports executive alignment on investment and expansion opportunities by highlighting key market drivers and regulatory shifts shaping the combination vaccine sector.

Conclusion

The five-in-one DTaP-Hib-IPV vaccine market is positioned for sustained growth, guided by advances in product integration, resilient supply systems, and cross-sector collaboration. Senior leaders can leverage this insight to optimize operational performance and strengthen pediatric immunization outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in combination vaccine adjuvants improving immunogenicity and safety of DTaP-Hib-IPV
5.2. Regulatory approvals and policy shifts accelerating adoption of pentavalent DTaP-Hib-IPV vaccines
5.3. Supply chain innovations mitigating shortages in pentavalent vaccine manufacturing and distribution
5.4. Emerging competitor launches of biosimilar pentavalent vaccines in emerging markets
5.5. Integration of pentavalent vaccination programs into national immunization schedules to improve coverage
5.6. Strategies by leading vaccine manufacturers to optimize production capacity for DTaP-Hib-IPV combination delivery
5.7. Impact of vaccine hesitancy and misinformation on uptake of combination pediatric vaccines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. 5-in-1 DTaP-Hib-IPV Vaccine Market, by End User
8.1. Introduction
8.2. Clinics
8.2.1. General Clinics
8.2.2. Pediatric Clinics
8.3. Hospitals
8.3.1. Government Hospitals
8.3.2. Private Hospitals
8.4. Immunization Centers
9. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Government Medical Stores
9.3. Hospital Pharmacies
9.3.1. Private Hospital Pharmacies
9.3.2. Public Hospital Pharmacies
9.4. Online Pharmacies
9.5. Retail Pharmacies
9.5.1. Chain Pharmacies
9.5.2. Independent Pharmacies
10. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Administration Route
10.1. Introduction
10.2. Intramuscular Injection
10.3. Subcutaneous Injection
11. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Dosage Form
11.1. Introduction
11.2. Freeze Dried
11.3. Liquid
12. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Packaging
12.1. Introduction
12.2. Multi Dose Vials
12.2.1. Five Dose Vials
12.2.2. Ten Dose Vials
12.3. Single Dose Prefilled Syringes
12.3.1. Glass Syringes
12.3.2. Plastic Syringes
13. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Age Group
13.1. Introduction
13.2. Children
13.3. Infants
13.4. Toddlers
14. Americas 5-in-1 DTaP-Hib-IPV Vaccine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi Pasteur S.A.
17.3.2. GlaxoSmithKline plc
17.3.3. Serum Institute of India Private Limited
17.3.4. PT Bio Farma (Persero) Tbk
17.3.5. Walvax Biotech Co., Ltd
17.3.6. Sinovac Biotech Ltd
17.3.7. Bharat Biotech International Limited
17.3.8. Biological E. Limited
17.3.9. Chengdu Institute of Biological Products Co., Ltd
17.3.10. Beijing Institute of Biological Products Co., Ltd
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET: RESEARCHAI
FIGURE 28. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 29. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET: RESEARCHCONTACTS
FIGURE 30. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY FREEZE DRIED, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY FREEZE DRIED, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY FIVE DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY FIVE DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY TEN DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY TEN DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GLASS SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY GLASS SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PLASTIC SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PLASTIC SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY INFANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY TODDLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY TODDLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 150. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 151. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 158. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 159. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 160. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 161. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 162. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 163. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. CANADA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 180. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 181. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 182. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 183. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 186. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 187. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. MEXICO 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY SINGLE DOSE PREFILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 287. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 296. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 297. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 300. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 301. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 302. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 303. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 304. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 305. GERMANY 5-IN-1 DTAP-HIB-IPV VACCINE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this 5-in-1 DTaP-Hib-IPV Vaccine Market report include:
  • Sanofi Pasteur S.A.
  • GlaxoSmithKline plc
  • Serum Institute of India Private Limited
  • PT Bio Farma (Persero) Tbk
  • Walvax Biotech Co., Ltd
  • Sinovac Biotech Ltd
  • Bharat Biotech International Limited
  • Biological E. Limited
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd

Related Topics

Related Reports

DA2PP Vaccine Market - Global Forecast 2025-2030 - Product Image

DA2PP Vaccine Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Malaria Vaccine Market - Global Forecast 2025-2030 - Product Image

Malaria Vaccine Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Respiratory Syncytial Virus Vaccines Market Size, Share & Trends Analysis Report By Type (Passive Immunization, Preventive Vaccines), By Technology, By Targeted Population, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Respiratory Syncytial Virus Vaccines Market Size, Share & Trends Analysis Report By Type (Passive Immunization, Preventive Vaccines), By Technology, By Targeted Population, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Tetanus Toxoid Vaccine Market Report 2025 - Product Image

Tetanus Toxoid Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Kinrix Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Kinrix Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.